Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide
对甲基化胶质母细胞瘤患者进行洛莫司汀/替莫唑胺放化疗后,残余肿瘤的定量评估是生存期的一个强有力的独立预测因子。
期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noae205
Zeyen, Thomas; Böhm, Laura; Paech, Daniel; Schäfer, Niklas; Tzaridis, Theophilos; Duffy, Cathrina; Nitsch, Louisa; Schneider, Matthias; Potthoff, Anna-Laura; Schneider-Rothhaar, Javen Lennard; Steinbach, Joachim Peter; Hau, Peter; Kowalski, Thomas; Seidel, Clemens; Krex, Dietmar; Grauer, Oliver; Goldbrunner, Roland; Zeiner, Pia Susan; Tabatabai, Ghazaleh; Galldiks, Norbert; Stummer, Walter; Hattingen, Elke; Glas, Martin; Gkika, Eleni; Vatter, Hartmut; Radbruch, Alexander; Herrlinger, Ulrich; Weller, Johannes; Schaub, Christina